Get in touch
555-555-5555
mymail@mailservice.com
Introducing CCD Partners' broking & introductions service
CCD Partners • July 5, 2020
CCD Partners is pleased to announce the launch of our new broking and introductions service, designed to make pro-active connections between business leaders and investors across the chemicals and life sciences industries.
CCD Partners is pleased to announce the launch of our new broking and introductions service, leveraging the unique private-market intelligence generated by the CCD Partners network.
Sitting alongside our existing M&A Advisory, Due Diligence, and Executive Search
services, CCD Partners’ new Broking service will offer private-market information on, and introductions between, business leaders and financial investors, either in relation to potential strategic/M&A opportunities, investment opportunities, or straight commercial introductions.
We have launched this service in response to sustained market demand for a light-touch success-only offering that can operate independently from or in conjunction with our more bespoke retained consultancy projects. As well as facilitating introductions, the service also provides a no-obligation channel of information on the fragmented and often opaque lower and middle market chemicals and life sciences sectors and the investors interested in them.
The Broking service is underpinned by a significant investment from CCD Partners into the ongoing development of a global database of lower and middle-market chemical and life sciences companies, including company profiles, corporate development strategies, and key leadership contacts.
Through the Broking service, private company owners who wish to be kept abreast of potential investors strategically interested in their business type, size, or geography can now be connected to a stream of bespoke opportunities and introductions without the need to formally ‘go to market’ in a full-scale sale process.
Similarly, strategic trade buyers, PE, and VC institutions can benefit from a greater flow of information on potential private-market investment opportunities aligned strongly with their strategies and criteria, either on a project-specific or ongoing basis.
To learn more about CCD Partners’ capabilities and track record in M&A and investment broking, please contact edmund.blogg@ccdpartners.com
CCD Partners is a consultancy specialised in corporate transformations in small and mid-market chemicals and life sciences businesses.
To organise a call with one of our partners please email contact@ccdpartners.com
Receive M&A news relevant to your business
At critical moments our clients engage us to provide pre-publicity "off-market" intelligence to give them the edge over the competition - we also provide up-to-the-minute public or "on-market" intelligence for free
Contact Us
RECENT POSTS
Market leading provider of formulated chemical process aids and foam control, PennWhite has been acquired by Manali Petrochemicals, part of the AM International Holdings group.
Global source of industrial gas news, views, and debate, gas world has been sold by John and Karen Raquet to the senior management team in an MBO, backed by Mobeus Equity Partners.
Polyblend UK Ltd is one of the market leaders in PVC based polymers. We are experts in manufacturing a comprehensive range of liquid plastisol and dispersion systems, complemented by our Speciality Distribution business supplying plasticisers, resins and PVC additives.
GFBiochemicals is a sustainable chemicals company that produces levulinic acid derivatives at commercial scale directly from biomass. Having perfected its technology, product, and certification, the company is entering a new phase of commercialization.
In the latest episode of the Chemical Transformations podcast , CCD Partners' Managing Partner Matt Dixon speaks with Ted Clark, former President and CEO of Royal Adhesives & Sealants, discussing his new book "Shipping Clerk to CEO: The Power of Curiosity, Will, and Self Directed Learning”. The book tells the story of Clark’s remarkable career journey from entry-level worker to CEO of a $240m chemical company by the age of 42.
Esteve Química purchases one of the UQUIFA Group's two pharmaceutical fine chemicals plants in Barcelona.
Specialty materials manufacturer Vertellus has acquired Polyscope Polymers B.V., a global leader in specialty additives for coatings, electronics applications, and engineering polymers.
Biosynth Carbosynth is a fully hybrid Research Products, Life Sciences Reagents and Custom Synthesis and Manufacturing Services Company with global research, manufacturing and distribution facilities. They are the supplier of choice for many in the pharmaceutical, life science, food, agrochemical, cosmetic and diagnostic sectors and manufacture and source a vast range of chemical and biochemical products.
Steve Allin co-founded Charnwood Molecular with Phil Page in 1998. 22 years later, the business has evolved dramatically from its origins as a spinout of Loughborough University. Backed by a partnership with Synova Capital, the company is now preparing to move into a former AstraZeneca research facility and has already completed its first M&A deal, acquiring Aurelia Bioscience in summer 2021. CCD Partners’ Matt Dixon spoke with Steve about the journey from full-time academia to running a high-growth market leader.
Aspire was founded in 2009. Aspire has an asset-light business model that focuses on R&D, business development and sales and marketing, while outsourcing manufacturing and distribution to specialist third parties. For more details see www.aspirepharma.co.uk.
CCD Partners
Insight | Network | Execution
We are a network of multi-disciplinary specialists united in the common purpose of identifying and delivering the full potential of innovative and impactful chemicals and life sciences businesses.
Get In Touch
